Targeting the Viral Nucleocapsid Protein in Anti-HIV-1 Therapy

E-ISSN： 1875-5607|8|1|24-35

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.8, Iss.1, 2008-01, pp. : 24-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Protein-Protein and Protein-Nucleic Acid Interactions for Anti-HIV Therapy

Current Pharmaceutical Design, Vol. 17, Iss. 33, 2011-11 ,pp. : 3713-3728

Bentham Science Publishers

Access to resources Recommend Favorite

The HIV-1 Nucleocapsid Zinc Finger Protein as a Target of Antiretroviral Therapy

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 15, 2004-11 ,pp. : 1605-1622

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting HIV-1 gp41-induced Fusion and Pathogenesis for Anti-viral Therapy

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 24, 2011-12 ,pp. : 2947-2958

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Protein-Protein Interactions: A Promising Avenue of Anti-HIV Drug Discovery

Current Medicinal Chemistry, Vol. 17, Iss. 29, 2010-10 ,pp. : 3393-3409

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in delivery systems for anti-HIV1 therapy

By Lanao José Briones Elsa Colino Clara

Journal of Drug Targeting, Vol. 15, Iss. 1, 2007-01 ,pp. : 21-36

Informa Healthcare

Access to resources Recommend Favorite